Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN75047591
ISRCTN75047591
Active, not recruiting
未知

Contrast enhanced digital CZT SPECT-CT for the diagnosis of parathyroid adenoma

inköping University Hospital0 sites45 target enrollmentApril 13, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
inköping University Hospital
Enrollment
45
Status
Active, not recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 13, 2023
End Date
June 30, 2023
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
inköping University Hospital

Eligibility Criteria

Inclusion Criteria

  • •Adult patients referred from the endocrinology department with suspicion of parathyroid adenoma

Exclusion Criteria

  • •Allergy to iodinated contrast media

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 4
Diagnostic performance of contrast-enhanced CT, Diffusion-weighted MRI and FDG-PET in pleural thickening -Prospective studyMesothelioma
JPRN-UMIN000011771Saitama Medical University International Medical Center100
Recruiting
Not Applicable
Delayed contrast-enhanced computed tomography for assessment of myocardial injury after coronavirus disease 2019 (COVID-19) infectiocoronavirus disease 2019 (COVID-19) infection
JPRN-UMIN000044762Hokkaido Cardiovascular Hospital400
Recruiting
Not Applicable
Contrast-enhanced computed tomography of the venous phase, not the arterial phase, is essential for the evaluation of the right phrenic nerve
JPRN-UMIN000051042niversity of Fukui60
Completed
Not Applicable
CODP Imaging From a Dose PerspectiveRadiation
NCT03581110Universitätsmedizin Mannheim1,957
Active, not recruiting
Phase 1
Prospective ultrasound based study of lymphatic vessels using ultrasound contrast agentMedDRA version: 20.0Level: LLTClassification code 10025233Term: LymphedemaSystem Organ Class: 100000004866MedDRA version: 20.0Level: LLTClassification code 10054561Term: Post-mastectomy lymphedema syndromeSystem Organ Class: 100000004863MedDRA version: 20.0Level: LLTClassification code 10036389Term: Postmastectomy lymphedema syndromeSystem Organ Class: 100000004863Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
EUCTR2018-004389-33-FIOlli Lahtinen160